John Greene
Fortuna: 381 780 $ al 30/06/2026
Fortuna: 381 780 $ al 30/06/2026
John T. Greene es director financiero y vicepresidente ejecutivo de Discover Financial Services. También forma parte del consejo de CRISPR Therapeutics AG. Anteriormente, el Sr. Greene fue director financiero de HSBC Holdings Plc y director financiero de Retail Bank & Wealth Management en HongKong & Shanghai Banking Corp. (Nueva York) (una filial de HSBC Holdings Plc), Director Financiero-Global Business Finance en General Electric Co., Director Financiero del Grupo Willis Group Holdings Plc, Director Financiero de HSBC Insurance Co. of Delaware y Director Financiero, Tesorero y Vicepresidente Ejecutivo de Bioverativ, Inc. Obtuvo un MBA en la Kellogg School of Management y una licenciatura en la State University of New York.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG 0,01 % | 05/06/2026 | 7.000 ( 0,01 % ) | 381 780 $ | 30/06/2026 |
| 11/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director/Miembro de la Junta | 11/06/2019 |
| NORTHROP GRUMMAN CORPORATION | Director Financiero/CFO | 07/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| DISCOVER FINANCIAL SERVICES | Director Financiero/CFO | 18/05/2025 |
| BIOVERATIV INC | Director Financiero/CFO | 01/01/2018 |
Willis Group Holdings Plc
Willis Group Holdings Plc Financial ConglomeratesFinance Operates as a holding company that through its subsidiaries provides insurance brokerage, reinsurance and consulting services | Director Financiero/CFO | 01/01/2016 |
HongKong & Shanghai Banking Corp. (New York)
HongKong & Shanghai Banking Corp. (New York) Regional BanksFinance Part of HSBC Holdings Plc, HongKong & Shanghai Banking Corp. (New York) is an American company. | Director Financiero/CFO | 01/05/2014 |
HSBC Insurance Co. of Delaware
HSBC Insurance Co. of Delaware Insurance Brokers/ServicesFinance Provides insurance services | Director Financiero/CFO | 01/05/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
GE Aerospace
GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
HSBC Holdings Plc
HSBC Holdings Plc Major BanksFinance Operates as a bank holding company with interest in providing national banking services | Finance |
Northrop Grumman Corp.
Northrop Grumman Corp. Aerospace & DefenseElectronic Technology Designs and manufactures space, mission, aeronautical & missile systems | Electronic Technology |
Willis Group Holdings Plc
Willis Group Holdings Plc Financial ConglomeratesFinance Operates as a holding company that through its subsidiaries provides insurance brokerage, reinsurance and consulting services | Finance |
Discover Financial Services
Discover Financial Services Finance/Rental/LeasingFinance Provides online banking, credit card, personal & home loan and online banking services | Finance |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HongKong & Shanghai Banking Corp. (New York)
HongKong & Shanghai Banking Corp. (New York) Regional BanksFinance Part of HSBC Holdings Plc, HongKong & Shanghai Banking Corp. (New York) is an American company. | Finance |
HSBC Insurance Co. of Delaware
HSBC Insurance Co. of Delaware Insurance Brokers/ServicesFinance Provides insurance services | Finance |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Bioverativ, Inc.
Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.